Puma Biotechnology to present its abstract at ESMO 2017

ME PubManu Team

Puma Biotechnology, Inc., a biopharmaceutical company announces the release of two abstracts on its drug neratinib. It will be presented at the European Society for Medical Oncology (ESMO) 2017 Congress, which is to be held from September 8 – 12 in Madrid, Spain.

Reference Link: http://markets.businessinsider.com/news/stocks/puma-biotechnology-announces-publication-of-abstracts-for-esmo-2017-1002296389

Related Posts

Best Impact Factor Results for Emerald Publishing

The 2016 Journal Citation Report released by Clarivate Analytics shows Emerald Publishing journals to be the best performing in terms of citation (upto 41%) and impact factor. Reference Link: http://www.stm-publishing.com/emerald-publishing-delivers-best-ever-impact-factor-results/ Share via: Facebook X (Twitter) LinkedIn More

Brexit Impact on EU Grant Application

Brexit has given a hard time to the British medical researchers. The EU research grant forums are not strike off the British medical researchers from their applications post-Brexit. Barring the Britain researchers from accessing European funding may threaten the advancement researches in the field of medical science, in which Britain takes over the forefront position. […]

Lab-Grown Human Embryo Models Illuminate Early Pregnancy Mysteries

In a groundbreaking achievement, scientists have successfully generated human embryo models using stem cells in a laboratory setting, shedding light on the critical first week after implantation in the uterine wall. This development promises valuable insights into fertility, early pregnancy loss, and developmental birth defects. Molecular geneticist Jacob Hanna of the Weizmann Institute of Science […]

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied